Summary by Alejandro Reyes (Photo credit: Presidential Secretariat Press Bureau)
Hearing the phrase “made in China”, many people immediately think of a low-quality, mass-produced product. This is not completely wrong but it is also not so true. Not all products made in China are of poor quality. This stereotype, however, has developed so widely that it tars other products from China that are of good quality, including vaccines.
Countries in the world have started to vaccinate their citizens to create herd immunity to Covid-19 so that the pandemic ends and community activities can return to normal. Since the pandemic hit, a number of countries have immediately developed vaccine-related research. Pfizer, Moderna, BioNTech, AstraZeneca, Sinovac, and a number of other pharmaceutical companies are competing to develop a Covid-19 vaccine using various methods.
For developed countries, funding is not an obstacle. It is different from developing countries, especially poor countries. Indonesia has chosen the Sinovac vaccine. This vaccine from China was doubted because of its efficacy – only 65 percent – which is key to meeting World Health Organization (WHO) standards. The doubts come from people who either believe more in Western products, or are anti-vaccine adherents, or hate China, or simply do not like the government's efforts at all.
Many are reluctant to be vaccinated first. They want to see the results and the impact on the volunteers who receive the injections first. To convince the public, President Joko Widodo was the first person to be vaccinated in Indonesia using the Sinovac product. Some alleged that it was not actually Sinovac, while some said that what the president got was not a vaccine but a vitamin.
Whatever the brand, vaccination is one way to end the pandemic. Millions of victims have fallen, and the economy has stagnated due to restrictions on activities. Vaccination is the way out so that our lives return to normal.